9101 POSTER Pre-planned Subgroup Analyses From the Phase III, Randomised, Placebo-controlled, Parallel-group Study of Gefitinib (G) as Maintenance Therapy in Patients (pts) With Locally Advanced or Metastatic Non-small-cell Lung Cancer (NSCLC) (INFORM; C-TONG 0804)

✍ Scribed by Zhang, L.; Ma, S.L.; Song, X.Q.; Cheng, Y.; Huang, C.; Yang, S.J.; Liu, X.Q.; Liu, Y.P.; Wang, M.Z.; Han, B.H.

• Book ID: 123121816
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 59 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)72413-3